Department of Neurology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Brain Inj. 2021 Sep 19;35(11):1462-1471. doi: 10.1080/02699052.2021.1972156. Epub 2021 Nov 9.
Cerebral ischemia is associated with a high burden of neurological disability. Recently, emerging evidence has demonstrated that long non-coding RNAs (lncRNAs) are crucial regulators in cerebral ischemia reperfusion (I/R) injury. Herein, we investigated the function and potential mechanism of long intergenic non-protein coding RNA 473 (LINC00473) in cerebral I/R injury.
We established oxygen glucose deprivation/reperfusion (OGD/R) model in Neuro-2a (N2a) cells to mimic the cerebral I/R injury in vitro. RT-qPCR and Western blot assays were conducted to detect target gene expression. Functional assays measured the effects of LINC00473 on cell viability, apoptosis and reactive oxygen species (ROS) production. A series of mechanism assays were carried out to detect the potential mechanism of LINC00473 in cerebral I/R injury.
LINC00473 was significantly down-regulated in OGD/R-induced injury model. LINC00473 overexpression reversed the reduced cell viability as well as the enhanced apoptosis and ROS level induced by OGD/R. Moreover, LINC00473 functioneds as a competing endogenous RNA (ceRNA) to sponge miR-15b-5p and miR-15a-5p and thereby regulated SRSF protein kinase 1 (SRPK1) expression.
Our findings confirmed the protective role of LINC00473 in cerebral I/R injury, which might provide a novel target for treating ischemic brain injury.
脑缺血与神经功能残疾负担高有关。最近,新出现的证据表明,长非编码 RNA(lncRNA)是脑缺血再灌注(I/R)损伤的重要调节因子。在此,我们研究了长基因间非蛋白编码 RNA 473(LINC00473)在脑 I/R 损伤中的作用和潜在机制。
我们建立了氧葡萄糖剥夺/再灌注(OGD/R)模型,在体外模拟脑 I/R 损伤。采用 RT-qPCR 和 Western blot 检测靶基因表达。功能测定测定 LINC00473 对细胞活力、凋亡和活性氧(ROS)产生的影响。进行了一系列机制测定,以检测 LINC00473 在脑 I/R 损伤中的潜在机制。
LINC00473 在 OGD/R 诱导的损伤模型中显著下调。LINC00473 的过表达逆转了 OGD/R 诱导的细胞活力降低以及凋亡和 ROS 水平升高。此外,LINC00473 作为竞争性内源性 RNA(ceRNA)与 miR-15b-5p 和 miR-15a-5p 结合,从而调节 SRSF 蛋白激酶 1(SRPK1)的表达。
我们的研究结果证实了 LINC00473 在脑 I/R 损伤中的保护作用,这可能为治疗缺血性脑损伤提供新的靶点。